You have completed % of this survey
Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

DMH Contracted Providers

BinaxNOW testing is available to our DMH approved/contracted community providers through DHSS.  Please complete this 2 to 3 question survey to help us identify your interest in this option by 3/5/2021. Once we determine interest, we will schedule a WebEx with providers and DHSS to review the requirements.  Additional information is below to assist you with your decision: 

 

  • BinaxNOW is a rapid, self-administered test (under the observation of a trained individual).
    • BinaxNOW can provide false negatives and false positives.  They are most accurate for symptomatic individuals.
      • Accuracy improves with more frequent use (daily, 2x, or 3x per week) for asymptomatic individuals.
  • Those wishing to order and administer BinaxNOW must have Dr.’s order to administer tests.
    • If a facility has a medical director or physician, it would be under their order. 
    • Facilities without a medical director or physician could utilize a standing order from the State Department of Health and Senior Services.  
  • Those wishing to order and administer must have a CLIA waiver.
    • If you do not have one, facilities may utilize the CLIA waiver through the State Public Health Laboratory.
  • Those wishing to order and administer must complete training requirements and documentation requirements.
    • The State Public Health Laboratory has online training modules that facilities must complete, as well as the appropriate documentation of that training.
    • Anyone who goes through the training can administer a BinaxNOW test. 
    • Once trainings are complete, you can begin ordering and using the tests.
    • Facilities must report EVERY test result  (positive and negative) to the Department of Health and Senior Services.
      • There is a prescribed method for reporting that will be part of the training requirements.
  • At this time there is no charge for the tests but that may change in the next couple months. 
    • DMH will continue to cover testing costs for providers so long as we have access to CARES Act funding for this purpose. 
    • Anticipated costs for BinaxNOW would be $10 or less per test.
There are 3 questions in this survey.